Viewing Study NCT06012435


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-25 @ 7:39 PM
Study NCT ID: NCT06012435
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2023-08-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module